Moving more and sitting less could lower the risk of adverse pregnancy outcomes, according to a new study published in the ...

An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In ...

Being admitted to a mental health unit can be one of the most vulnerable moments in a person's life. They often arrive in the midst of a crisis, and are fearful, confused, and anxious. But in these ...

A University of California, Riverside-led study has found that heavily used high-puff electronic cigarettes may contain higher levels of harmful chemicals than fresh e-cigarettes, raising concerns ...

Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to ...

A new Columbia study has found clues of Alzheimer's beginnings, revealing how tau filaments—protein clumps that are closely linked to memory decline in Alzheimer's disease—get their start. The finding ...

People with celiac disease and dermatitis herpetiformis have a slightly increased risk of cardiovascular disease, certain types of blood cancer, and premature death. This is shown by a large U.S.

Neuropsychology researchers at LMU have discovered a rhythm in the midbrain that could serve as a biophysiological signature for specific states of consciousness.

The UN health chief was on Friday in the Democratic Republic of Congo, where authorities are struggling to contain the spread of a deadly Ebola outbreak but the recovery of a patient, the first since ...

A Kenyan court has reportedly shut down a plan set in motion by the Trump administration to quarantine Ebola-exposed Americans in Kenya.

In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR ...